nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

11.01.2022 | COVID-19 | Original Article Zur Zeit gratis

Are Low Serum Vitamin D Levels a Risk Factor for Advent of COVID-19 Associated Rhinocerebral Mucormycosis: A Preliminary Case Control Study

verfasst von: Harsha Popli, Ambika Gupta, Virendra Singh, Varsha Agarwal, R. Akilan, Adarsh Kumar

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

To determine whether low serum vitamin D level is a risk factor for development of Rhinocerebral mucormycosis in COVID-19 afflicted patients. A case control study was conducted in a tertiary care hospital utilizing the archived records of COVID-19 afflicted Rhinocerebral mucormycosis cases and age and gender matched controls. The mean value (± standard deviation) of vitamin D level in patients with Mucormycosis was 19.65 ± 13.07 ng/ml and in control subjects it was 27.88 ± 18.04 ng/ml.There was a significant difference between groups (p = 0.02). Thus, low Vitamin D level may be implicated as a risk factor for the advent of mucormycosis in a COVID-19 afflicted patient and therefore Vitamin D supplements may be provided to such patients to achieve normal serum levels.

Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:S23-34CrossRefPubMed

Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE (2005) Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun 73:778–783CrossRefPubMedPubMedCentral

Agarwal V, Gupta A, Singh V, Jajodia N, Popli H, Akilan R (2021) Association of COVID-19 with rhino-cerebral mucormycosis: an observational study. J Maxillofac Oral Surg 2021:1–5

Revannavar SM, Samaga L (2021) COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? BMJ Case Rep 14:e241663CrossRefPubMedPubMedCentral

Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A et al (2021) Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 186:289–298CrossRefPubMedPubMedCentral

Zmijewski MA (2019) Vitamin D and human health. Int J Mol Sci 20:E145CrossRef

Lang PO, Aspinall R (2017) Vitamin D status and the host resistance to infections: what it is currently (Not) understood. Clin Ther 39:930–945CrossRefPubMed

Kearns MD, Alvarez JA, Seidel N, Tangpricha V (2015) The impact of vitamin D on infectious disease: a systematic review of controlled trials. Am J Med Sci 349:245–262CrossRefPubMedPubMedCentral

Nimavat N, Singh S, Singh P, Singh SK, Sinha N (2021) Vitamin D deficiency and COVID-19: a case-control study at a tertiary care hospital in India. Ann Med Surg 68:102661CrossRef

10.

Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S (2020) Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep 10:20191CrossRefPubMedPubMedCentral

11.

Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G et al (2021) Does serum vitamin D level affect COVID-19 infection and its severity? A case-control study. J Am Coll Nutr 40:724–731CrossRefPubMed

12.

Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi-Aliabadi M, Jafarzadeh B et al (2021) The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case–control study of hospitalized patients in Tehran. Iran J Med Virol 93:2359–2364CrossRefPubMed

13.

Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18:556–569CrossRefPubMedPubMedCentral

14.

Ramadorai A, Ravi P, Narayanan V (2019) Rhinocerebral mucormycosis: a prospective analysis of an effective treatment protocol. Ann Maxillofac Surg 9:192–196CrossRefPubMedPubMedCentral

15.

Bouzid D, Merzouki S, Bachiri M, Ailane SE, Zerroug MM (2017) Vitamin D3 a new drug against Candida albicans. J Mycol Medicale 27:79–82CrossRef

16.

Lim JHJ, Ravikumar S, Wang Y-M, Thamboo TP, Ong L, Chen J et al (2015) Bimodal influence of vitamin D in host response to systemic candida infection-vitamin D dose matters. J Infect Dis 212:635–644CrossRefPubMed

17.

Muhvić-Urek M, Saltović E, Braut A, Kovačević PD (2020) Association between vitamin D and Candida-associated denture stomatitis. Dent J (Basel) 8(4):121. https://doi.org/10.3390/dj8040121CrossRefPubMed

18.

Nguyen NLH, Pilewski JM, Celedón JC, Mandalapu S, Blanchard ML, DeRicco A et al (2015) Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study. Asthma Res Pract 1:3CrossRefPubMedPubMedCentral

19.

Dai J, Liang Y, Li H, Zhou W, Wang B, Gong A et al (2018) Vitamin D enhances resistance to aspergillus fumigatus in mice via inhibition of excessive autophagy. Am J Transl Res 10:381–391PubMedPubMedCentral

20.

Sirivoranankul C, Martinez M, Chen V, Clemons KV, Stevens DA (2014) Vitamin D and experimental invasive aspergillosis. Med Mycol 52:847–852CrossRefPubMed

21.

Jarvis JN, Bicanic T, Loyse A, Meintjes G, Hogan L, Roberts CH et al (2014) Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis. Clin Infect Dis Off Publ Infect Dis Soc Am 59:493–500CrossRef

22.

Martinaityte I, Kamycheva E, Didriksen A, Jakobsen J, Jorde R (2017) Vitamin D stored in fat tissue during a 5-year intervention affects serum 25-hydroxyvitamin D levels the following year. J Clin Endocrinol Metab 102:3731–3738CrossRefPubMed

23.

(2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33: S62–S69

24.

Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S-S1086CrossRefPubMed

25.

Sroussi HY, Burke-Miller J, French AL, Adeyemi OM, Weber KM, Lu Y et al (2012) Association among Vitamin D, oral candidiasis, and calprotectinemia in HIV. J Dent Res 91:666–670CrossRefPubMedPubMedCentral

26.

Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15:102146CrossRefPubMedPubMedCentral

27.

Gombart AF (2009) The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Fut Microbiol 4:1151–1165CrossRef

28.

Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB et al (2011) Antimicrobial implications of vitamin D. Dermatoendocrinology 3:220–229CrossRef

29.

Skrobot A, Demkow U, Wachowska M (2018) Immunomodulatory role of vitamin D: a review. Adv Exp Med Biol 1108:13–23CrossRefPubMed

30.

Mitri J, Pittas AG (2014) Vitamin D and diabetes. Endocrinol Metab Clin North Am 43:205–232CrossRefPubMed

Titel: Are Low Serum Vitamin D Levels a Risk Factor for Advent of COVID-19 Associated Rhinocerebral Mucormycosis: A Preliminary Case Control Study
verfasst von: Harsha Popli
Ambika Gupta
Virendra Singh
Varsha Agarwal
R. Akilan
Adarsh Kumar
Publikationsdatum: 11.01.2022
Verlag: Springer India
Schlagwort: COVID-19
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-022-03080-7

Neu im Fachgebiet HNO

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Are Low Serum Vitamin D Levels a Risk Factor for Advent of COVID-19 Associated Rhinocerebral Mucormycosis: A Preliminary Case Control Study

Abstract

Neu im Fachgebiet HNO

Eingreifen von Umstehenden rettet vor Erstickungstod!

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2022

Ingrained Insight into Nasal Polyposis; Role of Human Papillomavirus: An Indian Study

Current Practices and Recommendations for Prioritizing Patients Mimicking Upper Respiratory Tract Symptoms in Period of Covid 19 Pandemic: A Strategic Perspective

Approach to Management of Cerebrospinal Fluid Rhinorrhea: Institutional Based Protocol

Fibrovascular Polyp of the Cervical Esophagus: A Rare Neoplasm

Covid-19 Demographics from a Tertiary Care Center: Does It Depreciate Quality-of-Life?

Olfactory Dysfunction is Associated with More Severe Clinical Course in COVID-19

Neu im Fachgebiet HNO

Eingreifen von Umstehenden rettet vor Erstickungstod!

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Update HNO